Volunteers register to participate in NACOVAX trials (Source: VNA)Hanoi (VNA) – The of Vietnam’s COVID-19 vaccine will
begin on January 21-22, Health Minister Nguyen Thanh Long has stated.
has been developed by the Institute of Vaccines and
Medical Biologicals (IVAC) based in the south-central province of Khanh Hoa.
Volunteers will begin trials this month at the Hanoi Medical
University in the capital. It has already been tested on rabbits and mice.
This is the second Vietnam-produced COVID-19 vaccine to be
tested on human. The country is expected to start clinical trials on the third
vaccine in March.
According to Minister Long, Vietnam is one of the few ASEAN countries
that have tested on human. In addition, Vietnam has been one
of the first four countries to perform the gene sequencing of the SARS-CoV-2
and one of the five countries that can produce antibody diagnostic bio-products.
On December 17, 2020, the first Vietnam-made COVID-19 vaccine
NANOCOVAX developed by Nanogen Pharmaceutical Biotechnology JSC started human
trials with volunteers receiving the first doses at the Military Medical
University in Hanoi.
The volunteers remain in a healthy condition after receiving
two doses each./.
Source: VietnamPlus
